H. B. Bratcher, J. S. Bennett, and M. C. Maiden, Evolutionary and genomic insights into meningococcal biology, Future Microbiol, vol.7, pp.873-85, 2012.

N. E. Rosenstein, B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes, Meningococcal disease, N Engl J Med, vol.344, pp.1378-88, 2001.

C. L. Trotter, A. J. Fox, M. E. Ramsay, F. Sadler, S. J. Gray et al., Fatal outcome from meningococcal disease--an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin, J Med Microbiol, vol.51, pp.855-60, 2002.

M. L. Zarantonelli, M. Lancellotti, A. E. Deghmane, D. Giorgini, E. Hong et al., Hyperinvasive genotypes of Neisseria meningitidis in France, Clin Microbiol Infect, vol.14, pp.467-72, 2008.

A. E. Deghmane, C. Veckerle, D. Giorgini, E. Hong, C. Ruckly et al., Differential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis, PLoS Pathog, vol.5, p.1000405, 2009.

M. Van-deuren, J. Van-der-ven-jongekrijg, A. K. Bartelink, R. Van-dalen, R. W. Sauerwein et al., Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections, J Infect Dis, vol.172, pp.433-442, 1995.

H. Prigent, V. Maxime, and D. Annane, Clinical review: corticotherapy in sepsis, Crit Care, vol.8, pp.122-131, 2004.

D. Annane, Corticosteroids for severe sepsis: an evidence-based guide for physicians, Ann Intensive Care, vol.1, issue.7, 2011.

T. H. Nguyen, T. H. Tran, G. Thwaites, V. C. Ly, X. S. Dinh et al., Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis, N Engl J Med, vol.357, pp.2431-2471, 2007.

M. Scarborough, S. B. Gordon, C. J. Whitty, N. French, Y. Njalale et al., Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa, N Engl J Med, vol.357, pp.2441-50, 2007.

F. Madhi, C. Levy, A. E. Deghmane, S. Bechet, R. Cohen et al., Corticosteroid Therapy in Genotype ST-11 Meningococcal Infections, Pediatr Infect Dis J, vol.32, pp.291-294, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02092980

M. Szatanik, E. Hong, C. Ruckly, M. Ledroit, D. Giorgini et al., Experimental meningococcal sepsis in congenic transgenic mice expressing human transferrin, PLoS One, vol.6, p.22210, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02084270

A. E. Deghmane, I. Parent-du-chatelet, M. Szatanik, E. Hong, C. Ruckly et al., Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France, J Infect Dis, vol.202, pp.247-50, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-02085474

T. Guiddir, A. E. Deghmane, D. Giorgini, and M. K. Taha, Lipocalin 2 in cerebrospinal fluid as a marker of acute bacterial meningitis, BMC Infect Dis, vol.14, p.276, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-00996794

M. K. Taha, D. Giorgini, and X. Nassif, The pilA regulatory gene modulates the pilus-mediated adhesion of Neisseria meningitidis by controlling the transcription of pilC1, Mol Microbiol, vol.19, pp.1073-84, 1996.

M. L. Zarantonelli, A. Skoczynska, A. Antignac, M. El-ghachi, A. E. Deghmane et al., Penicillin resistance compromises Nod1-dependent proinflammatory activity and virulence fitness of Neisseria meningitidis, Cell Host Microbe, vol.13, pp.735-780, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02088904

O. Huet, D. Ramsey, S. Miljavec, A. Jenney, C. Aubron et al., Ensuring animal welfare while meeting scientific aims using a murine pneumonia model of septic shock, Shock, vol.39, pp.488-94, 2013.

B. Shrum, R. V. Anantha, S. X. Xu, M. Donnelly, S. M. Haeryfar et al., A robust scoring system to evaluate sepsis severity in an animal model, BMC Res Notes, vol.7, p.233, 2014.

O. Angelov, R. A. Schroer, S. Heft, V. C. James, and J. Noble, A comparison of two methods of bleeding rats: the venous plexus of the eye versus the vena sublingualis, J Appl Toxicol, vol.4, pp.258-60, 1984.

D. S. Kellogg, W. L. Peacock, J. Deacon, W. E. Brown, L. Pirkle et al., Neisseria gonorrhoeae. I. Virulence Genetically Linked to Clonal Variation, J Bacteriol, vol.85, pp.1274-1283, 1963.

M. L. Zarantonelli, M. Szatanik, D. Giorgini, E. Hong, M. Huerre et al., Transgenic mice expressing human transferrin as a model for meningococcal infection, Infect Immun, vol.75, pp.5609-5623, 2007.

A. Waage, A. Halstensen, and T. Espevik, Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease, Lancet, vol.1, pp.355-362, 1987.

K. Sjöstrom, C. Spindler, A. Ortqvist, M. Kalin, A. Sandgren et al., Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen, Clin Infect Dis, vol.42, pp.451-460, 2006.

D. R. Salgado, J. R. Rocco, E. Silva, and J. L. Vincent, Modulation of the renin-angiotensinaldosterone system in sepsis: a new therapeutic approach?, Expert Opin Ther Targets, vol.14, pp.11-20, 2010.

K. N. Couper, D. G. Blount, and E. M. Riley, IL-10: the master regulator of immunity to infection, J Immunol, vol.180, pp.5771-5778, 2008.

P. Brandtzaeg, A. Bjerre, R. Ovstebo, B. Brusletto, G. B. Joo et al., Neisseria meningitidis lipopolysaccharides in human pathology, J Endotoxin Res, vol.7, pp.401-421, 2001.

U. Gopinathan, R. Ovstebo, O. K. Olstad, B. Brusletto, D. Aass et al., Global effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes, Infect Immun, vol.80, pp.4046-54, 2012.

C. Gerard, C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele et al., Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia, J Exp Med, vol.177, pp.547-50, 1993.

M. Howard, T. Muchamuel, S. Andrade, and S. Menon, Interleukin 10 protects mice from lethal endotoxemia, J Exp Med, vol.177, pp.1205-1213, 1993.

S. Q. Latifi, M. A. O'riordan, and A. D. Levine, Interleukin-10 controls the onset of irreversible septic shock, Infect Immun, vol.70, pp.4441-4447, 2002.

R. N. Germain, Maintaining system homeostasis: the third law of Newtonian immunology, Nat Immunol, vol.13, pp.902-908, 2012.

H. D. Volk, P. Reinke, and W. D. Docke, Clinical aspects: from systemic inflammation to 'immunoparalysis', Chem Immunol, vol.74, pp.162-77, 2000.